These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33836890)

  • 1. Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study.
    Seftel MD; Chitphakdithai P; Miller JP; Kobusingye H; Logan BR; Linenberger M; Artz AS; Haight AE; Jacobsohn DA; Litzow MR; Magalhaes-Silverman M; Selby GB; Vusirikala M; Horowitz MM; Switzer GE; Confer DL; Shaw BE; Pulsipher MA
    Transplant Cell Ther; 2021 Apr; 27(4):352.e1-352.e5. PubMed ID: 33836890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.
    Farhadfar N; Ahn KW; Bo-Subait S; Logan B; Stefanski HE; Hsu JW; Panch S; Confer D; Liu H; Badawy SM; Beitinjaneh A; Diaz MA; Hildebrandt GC; Kelkar AH; Lazarus HM; Murthy HS; Preussler JM; Schears RM; Sharma A; van der Poel M; Bruce JG; Pulsipher MA; Shaw BE; Wingard JR; Switzer GE
    Transplant Cell Ther; 2022 Sep; 28(9):603.e1-603.e7. PubMed ID: 35688325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
    Yanagisawa R; Hirakawa T; Doki N; Ikegame K; Matsuoka KI; Fukuda T; Nakamae H; Ota S; Hiramoto N; Ishikawa J; Ara T; Tanaka M; Koga Y; Kawakita T; Maruyama Y; Kanda Y; Hino M; Atsuta Y; Yabe H; Tsukada N
    Int J Hematol; 2023 Mar; 117(3):421-427. PubMed ID: 36403180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
    Pulsipher MA; Logan BR; Chitphakdithai P; Kiefer DM; Riches ML; Rizzo JD; Anderlini P; Leitman SF; Varni JW; Kobusingye H; Besser RM; Miller JP; Drexler RJ; Abdel-Mageed A; Ahmed IA; Akard LP; Artz AS; Ball ED; Bayer RL; Bigelow C; Bolwell BJ; Broun ER; Bunin NJ; Delgado DC; Duckworth K; Dvorak CC; Hahn TE; Haight AE; Hari PN; Hayes-Lattin BM; Jacobsohn DA; Jakubowski AA; Kasow KA; Lazarus HM; Liesveld JL; Linenberger M; Litzow MR; Longo W; Magalhaes-Silverman M; McCarty JM; McGuirk JP; Mori S; Prasad VK; Rowley SD; Rybka WB; Sahdev I; Schriber JR; Selby GB; Shaughnessy PJ; Shenoy S; Spitzer T; Tse WT; Uberti JP; Vusirikala M; Waller EK; Weisdorf DJ; Yanik GA; Navarro WH; Horowitz MM; Switzer GE; Shaw BE; Confer DL
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):699-711. PubMed ID: 30423480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors.
    Rüesch M; Amar El Dusouqui S; Buhrfeind E; Buser A; Chalandon Y; Frey BM; Güngör T; Holbro A; Huguet S; Infanti L; Nair G; Nicoloso G; Passweg JR; Schanz U; Tiercy JM; Widmer I; Zeilhofer U; Zurkinden L; Halter JP
    Bone Marrow Transplant; 2022 Jun; 57(6):918-924. PubMed ID: 35379914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of improved JACIE standards on the care of related BM and PBSC donors.
    Anthias C; Ethell ME; Potter MN; Madrigal A; Shaw BE
    Bone Marrow Transplant; 2015 Feb; 50(2):244-7. PubMed ID: 25387092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study.
    Switzer GE; Bruce JG; Kiefer DM; Kobusingye H; Abebe KZ; Drexler R; Besser RM; Confer DL; Horowitz MM; King RJ; Shaw BE; Riches M; Hayes-Lattin B; Linenberger M; Bolwell B; Rowley SD; Litzow MR; Pulsipher MA
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2365-2371. PubMed ID: 32829080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe events in donors after allogeneic hematopoietic stem cell donation.
    Halter J; Kodera Y; Ispizua AU; Greinix HT; Schmitz N; Favre G; Baldomero H; Niederwieser D; Apperley JF; Gratwohl A
    Haematologica; 2009 Jan; 94(1):94-101. PubMed ID: 19059940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
    Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman OF; Kobusingye H; Besser RM; Miller JP; Drexler RJ; Abdel-Mageed A; Ahmed IA; Akard LP; Artz AS; Ball ED; Bayer RL; Bigelow C; Bolwell BJ; Broun ER; Delgado DC; Duckworth K; Dvorak CC; Hahn TE; Haight AE; Hari PN; Hayes-Lattin BM; Jacobsohn DA; Jakubowski AA; Kasow KA; Lazarus HM; Liesveld JL; Linenberger M; Litzow MR; Longo W; Magalhaes-Silverman M; McCarty JM; McGuirk JP; Mori S; Parameswaran V; Prasad VK; Rowley SD; Rybka WB; Sahdev I; Schriber JR; Selby GB; Shaughnessy PJ; Shenoy S; Spitzer T; Tse WT; Uberti JP; Vusirikala M; Waller EK; Weisdorf DJ; Yanik GA; Navarro WH; Horowitz MM; Switzer GE; Confer DL; Shaw BE
    Haematologica; 2019 Apr; 104(4):844-854. PubMed ID: 30381298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
    Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
    Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34
    Stroncek DF; Shaw BE; Logan BR; Kiefer DM; Savani BN; Anderlini P; Bredeson CN; Hematti P; Ganguly S; Diaz MA; Abdel-Azim H; Ahmed I; Maharaj D; Seftel M; Beitinjaneh A; Seo S; Yared JA; Halter J; O'Donnell PV; Hale GA; DeFilipp Z; Lazarus H; Liesveld JL; Zhou Z; Munshi P; Olsson RF; Kasow KA; Szer J; Switzer GE; Chitphakdithai P; Shah N; Confer DL; Pulsipher MA
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):175-184. PubMed ID: 28958894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBSC collection from family donors in Japan: a prospective survey.
    Kodera Y; Yamamoto K; Harada M; Morishima Y; Dohy H; Asano S; Ikeda Y; Nakahata T; Imamura M; Kawa K; Kato S; Tanimoto M; Kanda Y; Tanosaki R; Shiobara S; Kim SW; Nagafuji K; Hino M; Miyamura K; Suzuki R; Hamajima N; Fukushima M; Tamakoshi A; ; Halter J; Schmitz N; Niederwieser D; Gratwohl A;
    Bone Marrow Transplant; 2014 Feb; 49(2):195-200. PubMed ID: 24076552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.
    Pulsipher MA; Chitphakdithai P; Miller JP; Logan BR; King RJ; Rizzo JD; Leitman SF; Anderlini P; Haagenson MD; Kurian S; Klein JP; Horowitz MM; Confer DL
    Blood; 2009 Apr; 113(15):3604-11. PubMed ID: 19190248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attrition at the final donor stage among unrelated haematopoietic stem cell donors: the British Bone Marrow Registry experience.
    Balassa K; Griffiths A; Winstone D; Li Y; Rocha V; Pawson R
    Transfus Med; 2019 Oct; 29(5):332-337. PubMed ID: 31209947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the haematopoietic stem cell donation experience: is there room for improvement?
    Billen A; Madrigal JA; Shaw BE
    Bone Marrow Transplant; 2014 Jun; 49(6):729-36. PubMed ID: 24464144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
    Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.
    Pahnke S; Larfors G; Axdorph-Nygell U; Fischer-Nielsen A; Haastrup E; Heldal D; Itälä-Remes M; Johansson JE; Kauppila M; Lenhoff S; Ljungman P; Niittyvuopio R; Sandstedt A; Hägglund H
    J Clin Apher; 2018 Jun; 33(3):226-235. PubMed ID: 28833474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.
    Switzer GE; Bruce JG; Harrington D; Haagenson M; Drexler R; Foley A; Confer D; Bishop M; Anderlini P; Rowley S; Leitman SF; Anasetti C; Wingard JR
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):118-27. PubMed ID: 24184336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.
    Gordon SV; Nivison-Smith I; Szer J; Chapman JR
    Intern Med J; 2013 Nov; 43(11):1183-90. PubMed ID: 24007325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.